An MRI technique to quantify the amount of fat in the bone marrow of people with sickle cell disease…
Articles by Lindsey Shapiro, PhD
Vertex Pharmaceuticals will use ImmunoGen technology to develop less aggressive conditioning approaches for exagamglogene autotemcel (exa-cel), its experimental…
The risk of death from end-stage kidney disease (ESKD) has generally declined in the U.S. over the last 20…
Activation of a protein critical for the body’s response to low oxygen leads to increased levels of fetal hemoglobin in…
The prevalence of a genetic disorder affecting red blood cells, called glucose-6-phosphate dehydrogenase (G6PD) deficiency, was equally high among people…
A research team is conducting two projects to learn more about neurological problems, including cognitive impairment and stroke, in people…
Interfering with two newly identified proteins — NFIA and NFIX — involved both directly and indirectly in silencing fetal hemoglobin…
ARU-1801, Aruvant Sciences’ experimental gene therapy for sickle cell disease (SCD), led to the production of fetal hemoglobin…